Effect of Rice Bran Oil on Clinical and Biochemical Cardiovascular Parameters

Study on the Effect of Rice Bran Oil on Clinical and Biochemical Cardiovascular Parameters in Patients with Coronary Artery Disease

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190313043045N1

Enrollment

Registered

2019-04-27

Start date

2019-03-21

Completion date

Unknown

Last updated

2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease. Atherosclerotic heart disease of native coronary artery with unstable angina pectoris

Interventions

Intervention 1: Intervention group: consuming rice bran oil, 30 grams daily, for 8 weeks. Intervention 2: Control group: consuming sunflower oil, 30 grams daily, for 8 weeks.

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients aged 20-70 years old Recently undergoing angioplasty with coronary artery reocclussion

Exclusion criteria

Exclusion criteria: Use of vitamin and mineral supplements, antioxidants, fiber supplement, omega-3 Having a history of kidney disease Current consumption of alcoholic beverages

Design outcomes

Primary

Measure	Time frame
Weight. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: scale.;Systolic and diastolic blood pressure. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: barometer.;Total cholesterol. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: All the kits of the Pars laboratory test model Hitaeh viv.;TG, LDL, HDL, HSCRP, TNF-a. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: All the kits of the Pars laboratory test model Hitaeh viv.;Uric acid. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: All the kits of the Pars laboratory test model Hitaeh viv.;Fasting glucose. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: All the kits of the Pars laboratory test model Hitaeh viv.;EF score. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: echocardiography.;Severity of vascular involvement. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: severity of vascular involvement with measured syntax will be.	—

Measure

Time frame

Weight. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: scale.;Systolic and diastolic blood pressure. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: barometer.;Total cholesterol. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: All the kits of the Pars laboratory test model Hitaeh viv.;TG, LDL, HDL, HSCRP, TNF-a. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: All the kits of the Pars laboratory test model Hitaeh viv.;Uric acid. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: All the kits of the Pars laboratory test model Hitaeh viv.;Fasting glucose. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: All the kits of the Pars laboratory test model Hitaeh viv.;EF score. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: echocardiography.;Severity of vascular involvement. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: severity of vascular involvement with measured syntax will be.

—

Secondary

Measure	Time frame
?????. Timepoint: ?????. Method of measurement: ?????.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarjan Mahdavi Roshan

Rasht University of Medical Sciences

marjanmahdavi60@gmail.com+98 13 3361 8177

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 14, 2026